Amy R. Lankford

Amy Lankford currently serves as the Sr. Director and Head of Clinical Operations at Precigen since June 2019 and has held the position of Director of Clinical and Regulatory Development at Intrexon Corporation since June 2016. Prior experience includes work as a Protocol Developer at the University of Virginia Cancer Center from November 2011 to June 2016, where responsibilities involved designing and writing clinical trial protocols. Additionally, Amy was the Senior Manager of Therapeutic Development at Trovis Pharmaceuticals, LLC from April 2008 to October 2011, focusing on strategic planning and documentation for clinical trials. A Manager of Regulatory Affairs role at Adenosine Therapeutics, LLC was also fulfilled in 2008, with duties encompassing submission preparations for the FDA. Amy Lankford earned a PhD in Pharmacology from East Carolina University, where studies were completed from 1991 to 1996.